In line with ECNP’s mission to advance the science of the brain, promote better treatment and enhance brain health, developing the next generation of European clinical leaders has been a longstanding ECNP priority.
The ECNP Schools have been established to encourage excellence in future leaders in clinical neuropsychopharmacology by propagating best practices during a week-long in-person course, in that way contributing to the continuing improvement of the field’s high standards of practice.
Per ECNP School, a maximum of 50 early career psychiatrists are accepted.
There are two ECNP Schools:
1. The ECNP School of Child and Adolescent Neuropsychopharmacology
An interactive programme and intense training in clinical paediatric neuropsychopharmacology.
Target group: early career child and adolescent psychiatrists.
Participants of the ECNP School Child and Adolescent Neuropsychopharmacology 2022.
2. The ECNP School of Neuropsychopharmacology
An interactive programme and intense training in neuropsychopharmacology for psychiatrists covering the fundamentals of neuropsychopharmacology through to the use of medications in individual indications, good clinical practice and optimal treatment and algorithms.
Target group: early career psychiatrists.
Participants of the ECNP School of Neuropsychopharmacology Virtual 2021.
Experiences from previous Schools
|"It was an amazing experience, we learned so many new things, shared so many experiences, brainstormed with each other, made new friends. We'll have great memories for a long time."
Ana Munjiza, Serbia
"It was a great week, both from a clinical/scientific and a social perspective."
Anders Jørgensen, Denmark
Visit our history page for more info about our past ECNP Schools.
The ECNP Schools are funded by the ECNP Scholarship and Research Foundation (R&S), a public-interest-serving entity.